Hematology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Hematology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Hematology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.Hematology Tests which evaluates numerous conditions involving blood and its components and the tests that generate results immediately and can be done in limited resource setting.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hematology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hematology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- 2 Table of Contents
- 1 About GlobalData
- 2 Table of Contents
- 2.1 List of Tables
- 2.2 List of Figures
- 3 Introduction
- 3.1 Hematology Overview
- 4 Products under Development
- 4.1 Hematology - Pipeline Products by Stage of Development
- 4.2 Hematology - Pipeline Products by Segment
- 4.3 Hematology - Pipeline Products by Territory
- 4.4 Hematology - Pipeline Products by Regulatory Path
- 4.5 Hematology - Pipeline Products by Estimated Approval Date
- 4.6 Hematology - Ongoing Clinical Trials
- 5 Hematology - Pipeline Products under Development by Companies
- 5.1 Hematology Companies - Pipeline Products by Stage of Development
- 5.2 Hematology – Companies Pipeline Products by Stage of Development
- 6 Hematology Companies and Product Overview
- 6.1 AbSorber AB Company Overview
- 6.1.1 AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
- 6.2 Aggredyne Inc Company Overview
- 6.2.1 Aggredyne Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.3 Alba Bioscience Limited Company Overview
- 6.3.1 Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
- 6.4 Amity University Company Overview
- 6.4.1 Amity University Pipeline Products & Ongoing Clinical Trials Overview
- 6.5 Analyticon Biotechnologies AG Company Overview
- 6.5.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
- 6.6 Biofortuna Ltd Company Overview
- 6.6.1 Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.7 Blaze Medical Devices, LLC Company Overview
- 6.7.1 Blaze Medical Devices, LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.8 Calviri Inc Company Overview
- 6.8.1 Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.9 Cellphire Inc Company Overview
- 6.9.1 Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.10 Children's Hospital of Philadelphia Company Overview
- 6.10.1 Children's Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview
- 6.11 CPSI Biotech Company Overview
- 6.11.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
- 6.12 CW Optics Inc Company Overview
- 6.12.1 CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.13 Diagnostica Stago Inc Company Overview
- 6.13.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.14 DNA Medicine Institute (DMI) Inc Company Overview
- 6.14.1 DNA Medicine Institute (DMI) Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.15 ELITechGroup Inc Company Overview
- 6.15.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.16 Embryyo Technologies Pvt Ltd Company Overview
- 6.16.1 Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.17 Endpoint Health Inc Company Overview
- 6.17.1 Endpoint Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.18 Genome Diagnostics B.V. Company Overview
- 6.18.1 Genome Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview
- 6.19 Grifols SA Company Overview
- 6.19.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.20 Haemokinesis Pty Ltd Company Overview
- 6.20.1 Haemokinesis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.21 Haemonetics Corp Company Overview
- 6.21.1 Haemonetics Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.22 In Vitro Diagnostic Solutions Inc Company Overview
- 6.22.1 In Vitro Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.23 Indian Institute of Technology Bombay Company Overview
- 6.23.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
- 6.24 Instrumentation Laboratory Co Company Overview
- 6.24.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
- 6.25 King's College London Company Overview
- 6.25.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview
- 6.26 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview
- 6.26.1 Laboratorios Alpha San Ignacio Pharma S.L. Pipeline Products & Ongoing Clinical Trials Overview
- 6.27 LeukoLab Company Overview
- 6.27.1 LeukoLab Pipeline Products & Ongoing Clinical Trials Overview
- 6.28 Massachusetts General Hospital Company Overview
- 6.28.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
- 6.29 Medical University of Vienna Company Overview
- 6.29.1 Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview
- 6.30 MedPrime Technologies Pvt. Ltd. Company Overview
- 6.30.1 MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 6.31 Mylab Discovery Solutions Pvt Ltd Company Overview
- 6.31.1 Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.32 Nanospot.ai Inc Company Overview
- 6.32.1 Nanospot.ai Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.33 Neuron Biopharma SA Company Overview
- 6.33.1 Neuron Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.34 Northwestern University Company Overview
- 6.34.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
- 6.35 Ortho Clinical Diagnostics Holdings Plc Company Overview
- 6.35.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
- 6.36 PixCell Medical Technologies Ltd Company Overview
- 6.36.1 PixCell Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.37 Plakdx LLC Company Overview
- 6.37.1 Plakdx LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.38 Pro Test Diagnostics AB Company Overview
- 6.38.1 Pro Test Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
- 6.39 Quotient Ltd Company Overview
- 6.39.1 Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.40 Rapidx, Ltd. Company Overview
- 6.40.1 Rapidx, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 6.41 Redbud Labs Inc Company Overview
- 6.41.1 Redbud Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.42 Sebia SA Company Overview
- 6.42.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.43 SiDx Inc Company Overview
- 6.43.1 SiDx Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.44 Sigma Bio-Instrument Inc Company Overview
- 6.44.1 Sigma Bio-Instrument Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.45 Stichting Lygature Company Overview
- 6.45.1 Stichting Lygature Pipeline Products & Ongoing Clinical Trials Overview
- 6.46 Streck Inc Company Overview
- 6.46.1 Streck Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.47 TBG Diagnostics Ltd Company Overview
- 6.47.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.48 The University of British Columbia Company Overview
- 6.48.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
- 6.49 Transfusion & Transplantation Technologies (Inactive) Company Overview
- 6.49.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.50 University of California Los Angeles Company Overview
- 6.50.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
- 6.51 University of Utah Company Overview
- 6.51.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
- 6.52 Victory Square Health Inc Company Overview
- 6.52.1 Victory Square Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.53 Washington University in St Louis Company Overview
- 6.53.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
- 7 Hematology- Recent Developments
- 7.1 May 17, 2023: Abcam: Statement on potential extraordinary general meeting
- 7.2 May 17, 2023: Nihon Kohden announces consolidated financial results for the fiscal year ended March 31, 2023
- 7.3 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
- 7.4 May 12, 2023: Horiba announces summary of consolidated financial statements for the three months ended March 31, 2023
- 7.5 May 11, 2023: Haemonetics announces fourth quarter fiscal year 2023 earnings
- 7.6 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
- 7.7 May 11, 2023: Accelerate Diagnostics reports first quarter 2023 financial results
- 7.8 May 09, 2023: Grifols delivers strong first quarter financials with 23% revenue growth and an adjusted EBITDA margin above guidance of 21%
- 7.9 May 09, 2023: Redsense Medical announces interim report Q1 January - March, 2023
- 7.10 May 09, 2023: HCW Biologics reports first quarter 2023 financial results and recent business highlights
- 7.11 May 05, 2023: CellaVision: Bulletin from annual general meeting 2023
- 7.12 May 04, 2023: Kimball Electronics announces results for Q3 ended March 31, 2023
- 7.13 Apr 25, 2023: Haemonetics sets date for publishing fourth quarter and fiscal year 2023 results: May 11, 2023
- 7.14 Apr 21, 2023: Invitation to presentation of the CellaVision report for the first quarter 2023 on May 4, at 11:00 CEST
- 7.15 Apr 12, 2023: Medtronic has a layoff in California
- 7.16 Apr 06, 2023: Integrated Diagnostics Holdings Announces Final Results
- 7.17 Apr 06, 2023: Integrated Diagnostics Holdings concludes 2022 reporting solid 18% growth in non-Covid revenues
- 7.18 Apr 05, 2023: Hemcheck has received a first order from the university hospital Charité in Berlin
- 7.19 Apr 03, 2023: Cellavision Notice Of Annual General Meeting
- 7.20 Apr 03, 2023: Angle Notice of Preliminary Results and Webcast
- 7.21 Mar 30, 2023: Abcam Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting
- 7.22 Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022
- 7.23 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
- 7.24 Mar 15, 2023: Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results
- 7.25 Mar 14, 2023: Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement
- 7.26 Mar 08, 2023: Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors
- 7.27 Mar 03, 2023: Grifols Announces Full Year 2022 Earnings
- 7.28 Feb 22, 2023: Novo Nordisk Notice for the Annual General Meeting
- 7.29 Feb 16, 2023: Labcorp Announces 2022 Fourth Quarter and Full-Year Results
- 7.30 Feb 14, 2023: Horiba Announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2022
- 7.31 Feb 14, 2023: Hemcheck has received an additional follow up order from its UK distributor
- 7.32 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
- 7.33 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
- 7.34 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
- 7.35 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
- 7.36 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023
- 7.37 Feb 07, 2023: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2023 Results; Updates Fiscal 2023 Guidance
- 7.38 Feb 06, 2023: Kimball Electronics announces results for Q2 ended December 31, 2022
- 7.39 Feb 02, 2023: F. Hoffmann-La Roche Announces Financial Results for fiscal 2022
- 7.40 Feb 01, 2023: Novartis Announces Annual Report 2022
- 7.41 Feb 01, 2023: SDI Group Announces Board Appointment
- 7.42 Jan 30, 2023: Shionogi & Co Announces 3rd Quarter of Fiscal 2022 Financial Results
- 7.43 Jan 24, 2023: CellaVision's Invitation for presentation of the report for the fourth quarter 2022 on February 7, at 11:00 CET
- 7.44 Jan 16, 2023: TheraDiag Reports 2022 Revenue of €12.2 Million, up 9.7%
- 7.45 Jan 16, 2023: Hemcheck has received another follow up order from its Irish distributor
- 7.46 Jan 10, 2023: Kimball Electronics reports retirement of chairman and CEO
- 7.47 Jan 06, 2023: Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
- 7.48 Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
- 7.49 Jan 06, 2023: Abbott, Blood Centers of America launch first-of-its-kind mixed reality experience for use during blood donation
- 7.50 Jan 05, 2023: Angle : Announces business update
- 7.51 Dec 20, 2022: Hemcheck has received a follow up order from its Irish distributor
- 7.52 Dec 19, 2022: Vaxart Names Phillip Lee as Chief Financial Officer
- 7.53 Dec 13, 2022: Thomas Schinecker replaces Severin Schwan as Roche’s new CEO
- 7.54 Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report
- 7.55 Dec 07, 2022: HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform
- 7.56 Dec 07, 2022: Hemcheck has received an important follow up order from Deutsches Herzzentrum Berlin
- 7.57 Nov 25, 2022: Shionogi opens new European headquarters in Amsterdam
- 7.58 Nov 23, 2022: Medtronic Reports Quarterly Earnings
- 7.59 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
- 7.60 Nov 22, 2022: Hemcheck receives follow up order from its Italian distributor
- 7.61 Nov 17, 2022: Integrated Diagnostics Holdings 3rd Quarter Results
- 7.62 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
- 7.63 Nov 14, 2022: ProMIS Neurosciences Announces Third Quarter 2022 Financial Results and Recent Highlights
- 7.64 Nov 14, 2022: Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
- 7.65 Nov 14, 2022: OncoNano Medicine Announces New Preclinical Data for ON-BOARD Platform for Delivery of Bispecific T Cell Engagers and a Therapeutic Cytokine at the Society for Immunotherapy of Cancer Annual Meeting
- 7.66 Nov 11, 2022: Distribution agreement signed for the Italian market
- 7.67 Nov 11, 2022: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2022
- 7.68 Nov 10, 2022: Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
- 7.69 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
- 7.70 Nov 09, 2022: Redsense Medical Interim Report Q3 - July - September, 2022
- 7.71 Nov 09, 2022: Redsense Medical Announces Interim Report Q3 – July – September, 2022
- 7.72 Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023
- 7.73 Nov 08, 2022: Vaxart Provides Business Update and Reports Third Quarter 2022 Financial Results
- 7.74 Nov 08, 2022: Quanterix Corp. Releases Operating Results for Third Quarter 2022
- 7.75 Nov 07, 2022: HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights
- 7.76 Nov 03, 2022: Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance
- 7.77 Nov 01, 2022: Aspira Women’s Health to Announce Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 10
- 7.78 Oct 31, 2022: Shionogi announces 1st Half of Fiscal 2022 Financial Results
- 7.79 Oct 31, 2022: IDH and its Jordanian subsidiary, Biolab, to Launch Greenfield Diagnostic Venture in Saudi Arabia in Partnership with Izhoor Medical, a company owned by Fawaz Alhokair
- 7.80 Oct 27, 2022: Bio-Rad Reports Third-Quarter 2022 Financial Results
- 7.81 Oct 26, 2022: CellaVision announces Nomination Committee for the Annual General Meeting 2023
- 7.82 Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results
- 7.83 Oct 17, 2022: Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
- 7.84 Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring
- 7.85 Oct 13, 2022: Novartis to cut its Irish workforce by up to 25%
- 7.86 Oct 06, 2022: Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022
- 7.87 Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
- 7.88 Oct 04, 2022: Haemonetics appoints Roy Galvin as President, Global Plasma and Blood Center
- 7.89 Sep 30, 2022: Theradiag: Appointment of an Independent Expert
- 7.90 Sep 26, 2022: Leuko raises Series A funds to validate WBC monitoring solution
- 7.91 Sep 19, 2022: Theradiag Announces Its Results for the First Half of 2022: Breaking-Even and Confirming Its Ability to Be Structurally Profitable From Early 2023
- 7.92 Sep 15, 2022: New article brings forward support for home dialysis in connection with comorbidities
- 7.93 Sep 14, 2022: Horiba announces Review of First Half of 2022
- 7.94 Sep 07, 2022: Vaxart to Present at the H.C. Wainwright 24th Annual Global Investment Conference
- 7.95 Sep 07, 2022: Medtronic to appear at September investor conferences
- 7.96 Sep 06, 2022: Labcorp to Speak at the Baird 2022 Global Healthcare Conference
- 7.97 Sep 01, 2022: Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis
- 7.98 Sep 01, 2022: Abcam to participate in the Morgan Stanley 20th Annual Global Healthcare Conference
- 7.99 Sep 01, 2022: Angle PLC Notice of Interim Results and Webcast
- 7.100 Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference
- 7.101 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
- 7.102 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
- 7.103 Aug 23, 2022: Novartis set to eliminate many leadership positions as part of 1,400 layoffs in Switzerland
- 7.104 Aug 12, 2022: Horiba announce Summary of Consolidated Financial Statements for the Six Months Ended June 30, 2022
- 7.105 Aug 11, 2022: Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
- 7.106 Aug 10, 2022: Haemonetics Reports First Quarter Fiscal 2023 Results; Updates Fiscal 2023 Guidance; Announces New $300 Million Share Repurchase Authorization
- 7.107 Aug 08, 2022: Vaxart Provides Business Update and Reports Second Quarter 2022 Financial Results
- 7.108 Aug 04, 2022: Kimball Electronics announces results for Q4 and fiscal year ended June 30, 2022
- 7.109 Aug 01, 2022: GC Biopharma Reports Q2 2022 Results
- 7.110 Aug 01, 2022: Quanterix’ Second Quarter 2022 Earnings Conference Call
- 7.111 Jul 28, 2022: Labcorp Announces 2022 Second Quarter Results
- 7.112 Jul 28, 2022: Bio-rad Reports Second-quarter 2022 Financial Results
- 7.113 Jul 28, 2022: GC Care to start hiring experienced workers in the third quarter of 2022Platform Expert Recruitment
- 7.114 Jul 28, 2022: Grifols Report EUR 2,810.1 million revenues in first half of 2022
- 7.115 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
- 7.116 Jul 24, 2022: Central Trust Buys 136 Shares of Novartis AG
- 7.117 Jul 21, 2022: Roche: Appointed Thomas Schinecker as New CEO Effective March 15, 2023
- 7.118 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
- 7.119 Jul 18, 2022: Theradiag Reports Revenue of €6.3 Million for the First Half of 2022, Up 14.3%
- 7.120 Jul 18, 2022: Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
- 7.121 Jul 13, 2022: Anaveon appoints Dr Gary Phillips as Chief Business Officer
- 7.122 Jul 01, 2022: Hemcheck signed distribution agreement for the Spanish market
- 7.123 Jul 01, 2022: Novartis Leaning Toward Spinoff of $25 Billion Generics Arm
- 7.124 Jun 30, 2022: Novartis to cut up to 8,000 jobs globally
- 7.125 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
- 7.126 Jun 24, 2022: Quotient Ltd Provides Fourth Quarter Fiscal 2022 Results and Business Update
- 7.127 Jun 24, 2022: Quotient Provides Fourth Quarter Fiscal 2022 Results and Business Update
- 7.128 Jun 21, 2022: Quotient Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials
- 7.129 Jun 17, 2022: Quotient to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd
- 7.130 Jun 09, 2022: EKF Diagnostics Holdings : Launch of EKF Link
- 7.131 Jun 08, 2022: PixCell Medical Names Mark Erez as Chief Financial Officer
- 7.132 Jun 08, 2022: Integrated Diagnostics Holdings 1st Quarter 2022 Results
- 7.133 Jun 07, 2022: BD Names Simon Campion as Medical Segment President
- 7.134 Jun 02, 2022: BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
- 8 Appendix
- 8.1 Methodology
- 8.2 About GlobalData
- 8.3 Contact Us
- 8.4 Disclaimer
- 2.1 List of Tables
- Table 1: Hematology - Pipeline Products by Stage of Development
- Table 2: Hematology - Pipeline Products by Segment
- Table 3: Hematology - Pipeline Products by Territory
- Table 4: Hematology - Pipeline Products by Regulatory Path
- Table 5: Hematology - Pipeline Products by Estimated Approval Date
- Table 6: Hematology - Ongoing Clinical Trials
- Table 7: Hematology Companies - Pipeline Products by Stage of Development
- Table 8: Hematology – Companies Pipeline Products by Stage of Development
- Table 9: AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
- Table 10: ABO Diagnostic Test - Product Status
- Table 11: ABO Diagnostic Test - Product Description
- Table 12: Aggredyne Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 13: AggreGuide A-600 - Product Status
- Table 14: AggreGuide A-600 - Product Description
- Table 15: Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
- Table 16: ALBAclone Anti-C beta Reagent - Product Status
- Table 17: ALBAclone Anti-C beta Reagent - Product Description
- Table 18: ALBAclone Anti-e beta Reagent - Product Status
- Table 19: ALBAclone Anti-e beta Reagent - Product Description
- Table 20: ALBAclone Anti-H Reagent - Product Status
- Table 21: ALBAclone Anti-H Reagent - Product Description
- Table 22: ALBAcyte O Adult i Cell Reagent - Product Status
- Table 23: ALBAcyte O Adult i Cell Reagent - Product Description
- Table 24: ALBAcyte O RhD VI Reagent Cells - Product Status
- Table 25: ALBAcyte O RhD VI Reagent Cells - Product Description
- Table 26: Amity University Pipeline Products & Ongoing Clinical Trials Overview
- Table 27: Blood Group Testing Kit - Product Status
- Table 28: Blood Group Testing Kit - Product Description
- Table 29: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
- Table 30: Coagulyzer APTT Calibrator - Product Status
- Table 31: Coagulyzer APTT Calibrator - Product Description
- Table 32: Coagulyzer Calcium Chloride Calibrator - Product Status
- Table 33: Coagulyzer Calcium Chloride Calibrator - Product Description
- Table 34: Coagulyzer Calcium Chloride Control - Product Status
- Table 35: Coagulyzer Calcium Chloride Control - Product Description
- Table 36: Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 37: HemoPlex Kell Genotyping Kit - Product Status
- Table 38: HemoPlex Kell Genotyping Kit - Product Description
- Table 39: HemoPlex Kidd And Duffy Genotyping Kit - Product Status
- Table 40: HemoPlex Kidd And Duffy Genotyping Kit - Product Description
- Table 41: HemoPlex MNS Genotyping Kit - Product Status
- Table 42: HemoPlex MNS Genotyping Kit - Product Description
- Table 43: HemoPlex Multi Blood Group Genotyping Kit - Product Status
- Table 44: HemoPlex Multi Blood Group Genotyping Kit - Product Description
- Table 45: HemoPlex RHCE Screening Kit - Product Status
- Table 46: HemoPlex RHCE Screening Kit - Product Description
- Table 47: HemoPlex RHCE Variant Genotyping Kit - Product Status
- Table 48: HemoPlex RHCE Variant Genotyping Kit - Product Description
- Table 49: HemoPlex RHD And CE Genotyping Kit - Product Status
- Table 50: HemoPlex RHD And CE Genotyping Kit - Product Description
- Table 51: HemoPlex RHD Variant Genotyping Kit - Product Status
- Table 52: HemoPlex RHD Variant Genotyping Kit - Product Description
- Table 53: ThromboPlex HPA Screening Kit - Product Status
- Table 54: ThromboPlex HPA Screening Kit - Product Description
- Table 55: Blaze Medical Devices, LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 56: Fragility Test - Product Status
- Table 57: Fragility Test - Product Description
- Table 58: Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 59: Blood Screening Immunosignaturing - Product Status
- Table 60: Blood Screening Immunosignaturing - Product Description
- Table 61: Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 62: Thrombogent - Product Status
- Table 63: Thrombogent - Product Description
- Table 64: Children's Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview
- Table 65: Rh Antigen Screening Reagent - Product Status
- Table 66: Rh Antigen Screening Reagent - Product Description
- Table 67: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
- Table 68: FACSGuard - Product Status
- Table 69: FACSGuard - Product Description
- Table 70: CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 71: Optical Sensor - Product Status
- Table 72: Optical Sensor - Product Description
- Table 73: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 74: STA Compact Max - Apixaban Calibrators And Controls - Product Status
- Table 75: STA Compact Max - Apixaban Calibrators And Controls - Product Description
- Table 76: STA Compact Max - Dabigatran Calibrator And Control - Product Status
- Table 77: STA Compact Max - Dabigatran Calibrator And Control - Product Description
- Table 78: STA Compact Max - Edoxaban Calibrator And Control - Product Status
- Table 79: STA Compact Max - Edoxaban Calibrator And Control - Product Description
- Table 80: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status
- Table 81: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description
- Table 82: STA-R Max - Apixaban Calibrators And Controls - Product Status
- Table 83: STA-R Max - Apixaban Calibrators And Controls - Product Description
- Table 84: STA-R Max - Dabigatran Calibrator And Control - Product Status
- Table 85: STA-R Max - Dabigatran Calibrator And Control - Product Description
- Table 86: STA-R Max - Edoxaban Calibrator And Control - Product Status
- Table 87: STA-R Max - Edoxaban Calibrator And Control - Product Description
- Table 88: DNA Medicine Institute (DMI) Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 89: Stat Palm-Sized Blood Counter - Product Status
- Table 90: Stat Palm-Sized Blood Counter - Product Description
- Table 91: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 92: ELITe Ingenius Coagulation Factors Reagent - Product Status
- Table 93: ELITe Ingenius Coagulation Factors Reagent - Product Description
- Table 94: Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 95: Diagnostic Device - Bleeding Disorder - Product Status
- Table 96: Diagnostic Device - Bleeding Disorder - Product Description
- Table 97: Point Of Care Device - Platelet Function - Product Status
- Table 98: Point Of Care Device - Platelet Function - Product Description
- Table 99: Endpoint Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 100: Companion Diagnostic Test - Antithrombin III - Product Status
- Table 101: Companion Diagnostic Test - Antithrombin III - Product Description
- Table 102: Genome Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview
- Table 103: Blood Group Sequencing Assay - Product Status
- Table 104: Blood Group Sequencing Assay - Product Description
- Table 105: NGSgo-AmpX v2 Prototype Assay - Product Status
- Table 106: NGSgo-AmpX v2 Prototype Assay - Product Description
- Table 107: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
- Table 108: Extended Blood Typing Reagent - Product Status
- Table 109: Extended Blood Typing Reagent - Product Description
- Table 110: IH Blood Genotyping (D) Kit - Product Status
- Table 111: IH Blood Genotyping (D) Kit - Product Description
- Table 112: Haemokinesis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 113: Blood Incubator - Product Status
- Table 114: Blood Incubator - Product Description
- Table 115: Haemonetics Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 116: Four-Channel Platelet Mapping Cartridge - Product Status
- Table 117: Four-Channel Platelet Mapping Cartridge - Product Description
- Table 118: In Vitro Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 119: Single Analyte Detection Test - Product Status
- Table 120: Single Analyte Detection Test - Product Description
- Table 121: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
- Table 122: Hb Quantifier - Product Status
- Table 123: Hb Quantifier - Product Description
- Table 124: Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
- Table 125: HemosIL Apixaban Testing Assay - Product Status
- Table 126: HemosIL Apixaban Testing Assay - Product Description
- Table 127: King's College London Pipeline Products & Ongoing Clinical Trials Overview
- Table 128: Non-Transferrin-Bound Iron Assay - Product Status
- Table 129: Non-Transferrin-Bound Iron Assay - Product Description
- Table 130: Laboratorios Alpha San Ignacio Pharma S.L. Pipeline Products & Ongoing Clinical Trials Overview
- Table 131: Double Trust - Product Status
- Table 132: Double Trust - Product Description
- Table 133: LeukoLab Pipeline Products & Ongoing Clinical Trials Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook